LESLuis E. Soto-RamírezMDSlidesetHIVSalvador HIV Clinical Forum 2022Role of Nukes and Non-nukes in Current ART - Luis E. Soto-RamírezView Slideset
EPNEstevão Portela NunesMD, PhDSlidesetHIVSalvador HIV Clinical Forum 2022Role of PIs on Current ART - Estevão Portela NunesView Slideset
EKEsper KallasMD, PhDSlidesetHIVSalvador HIV Clinical Forum 2022PrEP On-Demand vs Conventional - Esper KallasView Slideset
MGMonica GandhiMD, MPHSlidesetHIVSalvador HIV Clinical Forum 2022Current and Evolving Therapeutic Options for Highly Treatment Experienced Patients - Monica GandhiView Slideset
MGMonica GandhiMD, MPHSlidesetHIVSalvador HIV Clinical Forum 2022Is Resistance a Concern When Starting ART - Monica GandhiView Slideset
ESEduardo SprinzMDSlidesetHIVSalvador HIV Clinical Forum 2022International and Local Guidelines - Focus on Patients' Needs - Eduardo SprinzView Slideset
MGMonica GomesMD, PhDSlidesetHIVSalvador HIV Clinical Forum 2022Clinical Case - Monica GomesView Slideset
GMGustavo MagalhãesMD, PhDSlidesetHIVSalvador HIV Clinical Forum 2022Clinical Case - Gustavo MagalhãesView Slideset
FBFabianna BahiaMD, PhDSlidesetHIVSalvador HIV Clinical Forum 2022Clinical Case - Fabianna BahiaView Slideset
TVTânia VergaraMD, PhDSlidesetHIVSalvador HIV Clinical Forum 2022Choosing the Best Regimen For Older Patients With Comorbidities - Tânia VergaraView Slideset
FBFabianna BahiaMD, PhDVideoHIVSalvador HIV Clinical Forum 2022Clinical Case (focused on highly treatment experienced patients) - Fabianna Bahia, MD, PhDView Video
RDRicardo DiazMDVideoHIVSalvador HIV Clinical Forum 2022Resistance to INSTI: what can we expect? - Ricardo Diaz, MDView Video
